Valuation: AtriCure, Inc.

Market Cap 283.88Cr 253.54Cr 235.85Cr 214.53Cr 405.06Cr 27TCr 406.81Cr 2.84TCr 1.11TCr 14TCr 1.07TCr 1.04TCr 45TCr P/E 2026 *
522x
P/E 2027 * 133x
Enterprise Value 268.7Cr 239.97Cr 223.24Cr 203.05Cr 383.38Cr 26TCr 385.04Cr 2.69TCr 1.05TCr 13TCr 1.01TCr 986.95Cr 43TCr EV / Sales 2026 *
4.43x
EV / Sales 2027 * 3.84x
Free-Float
96.24%
Yield 2026 *
-
Yield 2027 * -
1 day+5.62%
1 week+1.22%
Current month-0.69%
1 month+5.24%
3 months+61.49%
6 months+98.97%
Current year+41.08%
1 week 51.63
Extreme 51.63
56.6
1 month 51.63
Extreme 51.63
61.7
Current year 25.36
Extreme 25.36
61.7
1 year 25.36
Extreme 25.36
61.7
3 years 18.94
Extreme 18.94
61.7
5 years 18.94
Extreme 18.94
89.18
10 years 14.78
Extreme 14.78
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 59 18/07/2017
Director TitleAgeSince
Director/Board Member 55 02/11/2012
Director/Board Member 64 11/03/2013
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
23/09/26 Sell

Chief Technology Officer

-4,519 0.0089%
11/09/26 Sell

Director

-5,313 0.0104%
08/09/26 Sell

Chief Technology Officer

-3,657 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
+5.62%+1.22%+53.03%+38.08% 283.88Cr
+1.13%+2.15%-25.29%+2.94% 17TCr
+0.83%+2.43%-8.31%+17.77% 11TCr
+0.13%+0.69%-25.09%+3.95% 11TCr
+2.34%+2.49%-47.36%-10.38% 7.53TCr
+0.78%+4.79%+3.10%+73.94% 6.18TCr
+0.12%+3.62%+12.66%+67.70% 5.29TCr
+0.55%+3.93%-2.82%-30.87% 5.01TCr
+0.95%-0.08%-17.61%+17.13% 4.08TCr
-0.36%-1.46%+23.55%+1.23% 3.17TCr
Average +1.21%+1.87%-3.41%+18.15% 7.07TCr
Weighted average by Cap. +0.85%+2.09%-15.03%+13.58%

Financials

2026 *2027 *
Net sales 61Cr 54Cr 50Cr 46Cr 87Cr 5.87TCr 87Cr 606.21Cr 237.53Cr 2.99TCr 227.66Cr 222.68Cr 9.6TCr 68Cr 61Cr 56Cr 51Cr 97Cr 6.58TCr 97Cr 679.69Cr 266.32Cr 3.35TCr 255.26Cr 249.68Cr 11TCr
Net income 71.32L 63.7L 59.26L 53.9L 1.02Cr 69Cr 1.02Cr 7.13Cr 2.79Cr 35Cr 2.68Cr 2.62Cr 112.93Cr 2.09Cr 1.87Cr 1.74Cr 1.58Cr 2.98Cr 202.14Cr 2.99Cr 21Cr 8.18Cr 103.06Cr 7.84Cr 7.67Cr 330.72Cr
Net Debt -15Cr -14Cr -13Cr -11Cr -22Cr -1.47TCr -22Cr -151.87Cr -60Cr -749.41Cr -57Cr -56Cr -2.4TCr -23Cr -20Cr -19Cr -17Cr -32Cr -2.19TCr -32Cr -226.55Cr -89Cr -1.12TCr -85Cr -83Cr -3.59TCr
Projected Income Statement - Annual - AtriCure, Inc.
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
09/26/09 $55.81 +5.62% 7,12,510
08/26/08 $52.84 -0.88% 5,95,656
07/26/07 $53.31 -0.69% 7,53,529
06/26/06 $53.68 -4.77% 8,63,662
05/26/05 $56.37 +2.23% 10,95,536
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - AtriCure, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
55.81USD
Average target price
54.89USD
Spread / Average Target
-1.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AtriCure, Inc.
  1. Stock Market
  2. Stocks
  3. ATRC Stock